[Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir]
| Autor: | Ken Tanaka, Yukiko Fujimatsu, Yasumitsu Okubo, Masahisa Tanaka, Kotaro Oizumi, Kaori Shiraishi, Shigeki Fukahori, Hiroto Jojima, Junichi Honda |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Male
medicine.medical_specialty Anti-HIV Agents Anion gap Indinavir Gastroenterology Fatal Outcome Internal medicine Case fatality rate medicine Humans Acquired Immunodeficiency Syndrome Nucleoside analogue business.industry Stavudine Lamivudine Metabolic acidosis General Medicine Middle Aged medicine.disease Lactic acidosis Reverse Transcriptase Inhibitors Acidosis Lactic Drug Therapy Combination business medicine.drug |
| Zdroj: | Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 73(12) |
| ISSN: | 0387-5911 |
| Popis: | Recently, several class-related adverse events have been recognized with antiretroviral drugs. For nucleoside analogue reverse transcriptase inhibitors. (NRTI), lactic acidosis with hepatomegaly and hepatic steatosis have been reported. These appear to occur at a low frequency, but with a high fatality rate. We report a case of fatal lactic acidosis in a patient with acquired immunodeficiency syndrome (AIDS) treated with stavudine (d4T), lamivudine (3TC) and indinavir (IDV). A 48-year-old male AIDS patient was admitted with complaints of general fatigue and dyspnea. His medications at presentation included d4T, 3TC and IDV. Physical examination demonstrated icteric sclerae and abdominal tenderness with hepatomegaly. Laboratory data demonstrated a severe metabolic acidosis with an anion gap due to lactate accumulation. Despite intensive treatment, cardiorespiratory arrest occurred and this could not be resuscitated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|